Advertisement
U.S. markets open in 8 hours 18 minutes

ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
18.72+0.24 (+1.30%)
At close: 04:00PM EDT
18.23 -0.49 (-2.62%)
After hours: 06:49PM EDT
Advertisement
Show:
Annual
Upgrade to begin using 40 years of financial statements and get so much more.

Income Statement

All numbers in thousands
Upgrade to begin using 40 years of financial statements and get so much more.
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
726,437
726,437
517,235
484,145
441,755
Cost of Revenue
41,638
41,638
10,166
19,141
20,550
Gross Profit
684,799
684,799
507,069
465,004
421,205
Operating Expense
758,178
758,178
730,665
635,443
707,791
Operating Income
-73,379
-73,379
-223,596
-170,439
-286,586
Net Non Operating Interest Income Expense
17,234
17,234
6,610
591
6,610
Other Income Expense
5,109
5,109
3,542
2,329
-997
Pretax Income
-51,036
-51,036
-213,444
-167,519
-280,973
Tax Provision
10,250
10,250
2,531
351
611
Net Income Common Stockholders
-61,286
-61,286
-215,975
-167,870
-281,584
Diluted NI Available to Com Stockholders
-61,286
-61,286
-215,975
-167,870
-281,584
Basic EPS
-0.91
-0.37
-1.34
-1.05
-1.79
Diluted EPS
-0.91
-0.37
-1.34
-1.05
-1.79
Basic Average Shares
163,114
163,819
161,683
160,493
157,331
Diluted Average Shares
163,114
163,819
161,683
160,493
157,331
Total Operating Income as Reported
-73,379
-73,379
-223,596
-170,439
-286,586
Total Expenses
799,816
799,816
740,831
654,584
728,341
Net Income from Continuing & Discontinued Operation
-61,286
-61,286
-215,975
-167,870
-281,584
Normalized Income
-61,286
-61,286
-215,975
-167,870
-281,584
Interest Income
17,234
17,234
6,610
591
6,610
Net Interest Income
17,234
17,234
6,610
591
6,610
EBIT
-73,379
-73,379
-223,596
-170,439
-286,586
EBITDA
-67,827
-67,827
-221,570
-167,095
-283,654
Reconciled Cost of Revenue
41,638
41,638
10,166
19,141
20,550
Reconciled Depreciation
5,552
5,552
2,026
3,344
2,932
Net Income from Continuing Operation Net Minority Interest
-61,286
-61,286
-215,975
-167,870
-281,584
Normalized EBITDA
-67,827
-67,827
-221,570
-167,095
-283,654
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0